KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Assets (2016 - 2025)

Boston Scientific (BSX) has disclosed Assets for 17 consecutive years, with $43.7 billion as the latest value for Q4 2025.

  • Quarterly Assets rose 10.86% to $43.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.7 billion through Dec 2025, up 10.86% year-over-year, with the annual reading at $43.7 billion for FY2025, 10.86% up from the prior year.
  • Assets hit $43.7 billion in Q4 2025 for Boston Scientific, up from $42.7 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $43.7 billion in Q4 2025 to a low of $30.9 billion in Q1 2021.
  • Historically, Assets has averaged $35.5 billion across 5 years, with a median of $33.8 billion in 2023.
  • Biggest five-year swings in Assets: grew 0.22% in 2022 and later rose 12.16% in 2025.
  • Year by year, Assets stood at $32.2 billion in 2021, then increased by 0.74% to $32.5 billion in 2022, then increased by 8.21% to $35.1 billion in 2023, then increased by 12.12% to $39.4 billion in 2024, then increased by 10.86% to $43.7 billion in 2025.
  • Business Quant data shows Assets for BSX at $43.7 billion in Q4 2025, $42.7 billion in Q3 2025, and $41.6 billion in Q2 2025.